BA Walker, MA Jacobson, DA Knight, CA Salvatore, T Weir, D Zhou and TR Bai
University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, Canada.

The A3 adenosine receptor is widely expressed in human tissues with the most abundant expression in the lung and liver, but the predominant cellular localization and functions of this receptor in humans are unknown. Since adenosine influences the activation of circulating and resident inflammatory cells within the lung and leads to exaggerated airway narrowing in individuals with inflammatory airway disorders, we hypothesized that A3 receptor gene expression is localized to inflammatory cells and that gene expression is upregulated in airway inflammation. Lung and airway tissue were obtained at thoracotomy from nonsmoking subjects and subjects with inflammatory airway disorders associated with tobacco smoke or asthma. In situ hybridization identified A3 receptors in mesenchymal cells and eosinophils within the lamina propria of the airways and the adventitia of blood vessels, but not in mast cells. A3 receptor transcripts were highly expressed in peripheral blood eosinophils purified from atopic donors (6.36 +/- 0.60 pg/microg total RNA) in comparison with neutrophils (0.26 +/- 0.06 pg/microg) or mononuclear cells (0.9 +/- 0.15 pg/microg). Mean A3 receptor transcript abundance was greater in lung tissue from subjects with airway inflammation (0.33 +/- 0.04 pg/microg total RNA) than in normal lung (0.24 +/- 0.03 pg/microg total RNA, P = 0.035). The A3 receptor agonist N6-(4-amino-3-iodobenzyl)adenosine dose-dependently inhibited platelet activating factor-induced eosinophil chemotaxis to a maximum of 41%. This inhibitory effect was completely abolished by addition of the A3 receptor selective antagonist 3-(3-iodo-4- aminobenzyl)-8-(4-oxyacetate)phenyl-1-propylxanthine. We conclude that A3 receptors are primarily expressed on eosinophils in human lung, where they mediate inhibition of eosinophil chemotaxis. Specific A3 receptor ligands may be useful agents in the treatment of eosinophil- dependent diseases such as asthma and rhinitis.

This article has been cited by other articles:

				D. van der Hoeven, T. C. Wan, and J. A. Auchampach Activation of the A3 Adenosine Receptor Suppresses Superoxide Production and Chemotaxis of Mouse Bone Marrow Neutrophils Mol. Pharmacol., September 1, 2008; 74(3): 685 - 696. [Abstract] [Full Text] [PDF]

				S. M. Reynolds, R. Docherty, J. Robbins, D. Spina, and C. P. Page Adenosine induces a cholinergic tracheal reflex contraction in guinea pigs in vivo via an adenosine A1 receptor-dependent mechanism J Appl Physiol, July 1, 2008; 105(1): 187 - 196. [Abstract] [Full Text] [PDF]

				S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, S. V. Novitskiy, M. M. Dikov, M. R. Blackburn, I. Biaggioni, and I. Feoktistov Effect of A2B Adenosine Receptor Gene Ablation on Proinflammatory Adenosine Signaling in Mast Cells J. Immunol., June 1, 2008; 180(11): 7212 - 7220. [Abstract] [Full Text] [PDF]

				R. A. Brown, G. W. Clarke, C. L. Ledbetter, M. J. Hurle, J. C. Denyer, D. E. Simcock, J. E. Coote, T. J. Savage, R. D. Murdoch, C. P. Page, et al. Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects Eur. Respir. J., February 1, 2008; 31(2): 311 - 319. [Abstract] [Full Text] [PDF]

				S. J. Mustafa, A. Nadeem, M. Fan, H. Zhong, L. Belardinelli, and D. Zeng Effect of a Specific and Selective A2B Adenosine Receptor Antagonist on Adenosine Agonist AMP and Allergen-Induced Airway Responsiveness and Cellular Influx in a Mouse Model of Asthma J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1246 - 1251. [Abstract] [Full Text] [PDF]

				Y. Chen, R. Corriden, Y. Inoue, L. Yip, N. Hashiguchi, A. Zinkernagel, V. Nizet, P. A. Insel, and W. G. Junger ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors Science, December 15, 2006; 314(5806): 1792 - 1795. [Abstract] [Full Text] [PDF]

				S. Morello, K. Ito, S. Yamamura, K.-Y. Lee, E. Jazrawi, P. DeSouza, P. Barnes, C. Cicala, and I. M. Adcock IL-1beta and TNF-{alpha} Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-{kappa}B Binding to the Proximal Promoter J. Immunol., November 15, 2006; 177(10): 7173 - 7183. [Abstract] [Full Text] [PDF]

				H. W. J. Young, C.-X. Sun, C. M. Evans, B. F. Dickey, and M. R. Blackburn A3 Adenosine Receptor Signaling Contributes to Airway Mucin Secretion after Allergen Challenge Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 549 - 558. [Abstract] [Full Text] [PDF]

				H. Zhong, Y. Wu, L. Belardinelli, and D. Zeng A2B Adenosine Receptors Induce IL-19 from Bronchial Epithelial Cells, Resulting in TNF-{alpha} Increase Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 587 - 592. [Abstract] [Full Text] [PDF]

				J. B. Volmer, L. F. Thompson, and M. R. Blackburn Ecto-5'-Nucleotidase (CD73)-Mediated Adenosine Production Is Tissue Protective in a Model of Bleomycin-Induced Lung Injury J. Immunol., April 1, 2006; 176(7): 4449 - 4458. [Abstract] [Full Text] [PDF]

				J. L. Chunn, J. G. Molina, T. Mi, Y. Xia, R. E. Kellems, and M. R. Blackburn Adenosine-Dependent Pulmonary Fibrosis in Adenosine Deaminase-Deficient Mice J. Immunol., August 1, 2005; 175(3): 1937 - 1946. [Abstract] [Full Text] [PDF]

				H. Zhong, L. Belardinelli, T. Maa, and D. Zeng Synergy between A2B Adenosine Receptors and Hypoxia in Activating Human Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 2 - 8. [Abstract] [Full Text] [PDF]

				H. W. J. Young, J. G. Molina, D. Dimina, H. Zhong, M. Jacobson, L.-N. L. Chan, T.-S. Chan, J. J. Lee, and M. R. Blackburn A3 Adenosine Receptor Signaling Contributes to Airway Inflammation and Mucus Production in Adenosine Deaminase-Deficient Mice J. Immunol., July 15, 2004; 173(2): 1380 - 1389. [Abstract] [Full Text] [PDF]

				H. Zhong, L. Belardinelli, T. Maa, I. Feoktistov, I. Biaggioni, and D. Zeng A2B Adenosine Receptors Increase Cytokine Release by Bronchial Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 118 - 125. [Abstract] [Full Text] [PDF]

				S. L. Tilley, M. Tsai, C. M. Williams, Z.-S. Wang, C. J. Erikson, S. J. Galli, and B. H. Koller Identification of A3 Receptor- and Mast Cell-Dependent and -Independent Components of Adenosine-Mediated Airway Responsiveness in Mice J. Immunol., July 1, 2003; 171(1): 331 - 337. [Abstract] [Full Text] [PDF]

				H. Zhong, S. G. Shlykov, J. G. Molina, B. M. Sanborn, M. A. Jacobson, S. L. Tilley, and M. R. Blackburn Activation of Murine Lung Mast Cells by the Adenosine A3 Receptor J. Immunol., July 1, 2003; 171(1): 338 - 345. [Abstract] [Full Text] [PDF]

				M. Fan, W. Qin, and S. J. Mustafa Characterization of adenosine receptor(s) involved in adenosine-induced bronchoconstriction in an allergic mouse model Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1012 - L1019. [Abstract] [Full Text] [PDF]

				R. Polosa Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease Eur. Respir. J., August 1, 2002; 20(2): 488 - 496. [Abstract] [Full Text] [PDF]

				S. K. Banerjee, H. W. J. Young, J. B. Volmer, and M. R. Blackburn Gene expression profiling in inflammatory airway disease associated with elevated adenosine Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L169 - L182. [Abstract] [Full Text] [PDF]

				J. L. Chunn, H. W. J. Young, S. K. Banerjee, G. N. Colasurdo, and M. R. Blackburn Adenosine-Dependent Airway Inflammation and Hyperresponsiveness in Partially Adenosine Deaminase-Deficient Mice J. Immunol., October 15, 2001; 167(8): 4676 - 4685. [Abstract] [Full Text] [PDF]

				H. Zhong, J. L. Chunn, J. B. Volmer, J. R. Fozard, and M. R. Blackburn Adenosine-Mediated Mast Cell Degranulation in Adenosine Deaminase-Deficient Mice J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 433 - 440. [Abstract] [Full Text] [PDF]

				Z. Gao, B.-S. Li, Y.-J. Day, and J. Linden A3 Adenosine Receptor Activation Triggers Phosphorylation of Protein Kinase B and Protects Rat Basophilic Leukemia 2H3 Mast Cells from Apoptosis Mol. Pharmacol., January 1, 2001; 59(1): 76 - 82. [Abstract] [Full Text]

				M. R. Blackburn, J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems Metabolic Consequences of Adenosine Deaminase Deficiency in Mice Are Associated with Defects in Alveogenesis, Pulmonary Inflammation, and Airway Obstruction J. Exp. Med., July 10, 2000; 192(2): 159 - 170. [Abstract] [Full Text] [PDF]

				C. A. Salvatore, S. L. Tilley, A. M. Latour, D. S. Fletcher, B. H. Koller, and M. A. Jacobson Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells J. Biol. Chem., February 11, 2000; 275(6): 4429 - 4434. [Abstract] [Full Text] [PDF]

				J. S. Fedan Nucleosides and Nucleotides in the Lung . Role in Asthma Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 7 - 9. [Full Text]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]

				D. A. Knight, C. P. Lydell, D. Zhou, T. D. Weir, R. Robert Schellenberg, and T. R. Bai Leukemia Inhibitory Factor (LIF) and LIF Receptor in Human Lung . Distribution and Regulation of LIF Release Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 834 - 841. [Abstract] [Full Text]

				I. Feoktistov, A. E. Goldstein, and I. Biaggioni Role of p38 Mitogen-Activated Protein Kinase and Extracellular Signal-Regulated Protein Kinase Kinase in Adenosine A2B Receptor-Mediated Interleukin-8 Production in Human Mast Cells Mol. Pharmacol., April 1, 1999; 55(4): 726 - 734. [Abstract] [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]